Resumen de Investigación
Analyzed using Evidence Intelligence™

Switching to CGM Improves Glycaemic Quality in Type 1 Diabetes

Última actualización 12 de julio de 2026

Key finding

Transitioning from SMBG to CGM significantly reduced the overall GRI by 9.8 units (95% CI −13.3, −6.3).

This study evaluated the impact of switching from self-monitoring of blood glucose (SMBG) to continuous glucose monitoring (CGM) in adults with Type 1 diabetes, finding significant improvements in glycaemic quality.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the impact of switching from self-monitoring of blood glucose (SMBG) to continuous glucose monitoring (CGM) in adults with Type 1 diabetes, finding significant improvements in glycaemic quality.

Clinical relevance

Improved glycaemic control is crucial for individuals with Type 1 diabetes, as it can reduce the risk of long-term complications such as cardiovascular disease, neuropathy, and retinopathy. The findings support the use of CGM technology as a more effective management tool for diabetes, potentially leading to better health outcomes and quality of life for patients.

Keep in mind

The study's sample size may limit generalizability. The duration of the intervention was not specified. Potential biases in self-reported data could affect results.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Daniel P, Sofia SI, Henrik I, David K, Marcus L. Switching from Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring Significantly Improves Glycaemic Quality in Adults with Type 1 Diabetes. Frontiers in Clinical Diabetes and Healthcare. 2026;7:1767987. doi:10.3389/fcdhc.2026.1767987

Efectos Principales

Transitioning to CGM reduced the overall GRI by 9.8 units (95% CI −13.3, −6.3).

The hypoglycaemia component of GRI decreased by −1.8 (95% CI −2.4, −1.2).

The hyperglycaemia component of GRI decreased by −2.8 (95% CI −5.3, −0.4).

85.4% of participants maintained or improved their GRI zone classification.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Continuous glucose monitoring, Self-monitoring of blood glucose and GRI Zone Classification Maintenance or Improvement, Glycemia risk index.

Primary intervention

Continuous glucose monitoring

Primary outcomes

  • GRI Zone Classification Maintenance or Improvement
  • Glycemia risk index

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

3
Evidence pairs
3
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 64

2

Related topics

3

Evidence pairs

298

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 3 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Relación de evidencia

Insulin Delivery Systems and CGM Time in Range

Evidencia relacionada

Tema de evidencia

Glycemic Control

Guardar evidencia

Tema de evidencia

Diabetes Technology

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

Glycemia risk index

Continuous glucose monitoring → Glycemia risk index

Continuous glucose monitoring → Glycemia risk index

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

GRI Zone Classification Maintenance or Improvement

Continuous glucose monitoring → GRI Zone Classification Maintenance or Improvement

Continuous glucose monitoring → GRI Zone Classification Maintenance or Improvement

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Glycemia risk index

Self-monitoring of blood glucose → Glycemia risk index

Self-monitoring of blood glucose → Glycemia risk index

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • CGM use led to a significant decrease in overall GRI by 9.8 units.
  • Participants experienced a reduction in hypoglycaemia risk by 1.8 units.
  • 85.4% of participants maintained or improved their GRI zone classification.
who this applies

A quién se aplica

  • Adults diagnosed with Type 1 diabetes.
  • Individuals currently using self-monitoring of blood glucose methods.
keep in mind

Tener en Cuenta

  • Results may not apply to populations outside the study sample.
  • The long-term effects of switching to CGM were not assessed.
  • Further research is needed to confirm findings in diverse populations.
between the lines

Entre Líneas

  • The study's sample size may limit generalizability.
  • The duration of the intervention was not specified.
  • Potential biases in self-reported data could affect results.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Insulin Delivery Systems and CGM Time in Range, Insulin Delivery Systems and GRI Zone Classification Maintenance or Improvement.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Insulin Delivery Systems improve cgm time in range?

Strong Evidence

Insulin Delivery Systems may improve CGM Time in Range.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Glycemia risk index

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 17 supporting studies with generally consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
17 supporting studiesUpdated: Jul 2026

Does Continuous glucose monitoring improve gri zone classification maintenance or improvement?

Emerging Evidence

Continuous glucose monitoring appears to improve GRI Zone Classification Maintenance or Improvement.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    GRI Zone Classification Maintenance or Improvement

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Self-monitoring of blood glucose improve glycemia risk index?

Emerging Evidence

Current evidence does not show a clear benefit of Self-monitoring of blood glucose for Glycemia risk index.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Glycemia risk index

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.